Taburada, Felizardo M.

HRN: 03-12-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CO-AMOXICLAV 625MG (TAB)
06/23/2025
06/30/2025
PO
625
BID
Acute Pancreatitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines